Sign in

CIK 0001645469

  • Non-accelerated filer
  • Smaller reporting company

Monopar Therapeutics

Sign in to watch
Ticker
MNPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320463781
Phone
+1 847-388-0349
Business address
1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,335,315
in 9 filings, $5.3M under 10b5-1 plans

Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-30 Mazar Andrew Paul Chief Scientific Officer Shares withheld for taxes −942 $5.89 $6K 17,538.8
2021-06-30 Mazar Andrew Paul Chief Scientific Officer Exercise or conversion · Restricted Stock Units −3,212 22,485
2021-06-30 Robinson Chandler Chief Executive Officer Exercise or conversion +7,883 26,282.8
2021-06-30 Robinson Chandler Chief Executive Officer Shares withheld for taxes −2,310 $5.89 $14K 23,972.8
2021-06-30 Robinson Chandler Chief Executive Officer Exercise or conversion · Restricted Stock Units −7,883 55,177
2021-06-30 Cittadine Andrew Chief Operating Officer Grant or award · Stock Options +30,000 30,000
2021-06-01 Cittadine Andrew Chief Operating Officer Grant or award · Stock Options +70,000 70,000
2021-03-31 STARR CHRISTOPHER M Director Exercise or conversion +751 2,040
2021-03-31 STARR CHRISTOPHER M Director Exercise or conversion · Restricted Stock Units −751 2,254
2021-03-31 KLAUSNER ARTHUR J Director Exercise or conversion +751 7,040
2021-03-31 KLAUSNER ARTHUR J Director Exercise or conversion · Restricted Stock Units −751 2,254
2021-03-31 Brown Michael J Director Exercise or conversion +751 212,040
2021-03-31 Brown Michael J Director Exercise or conversion · Restricted Stock Units −751 2,254
2021-03-31 Anderson Raymond Director Exercise or conversion +751 3,040
2021-03-31 Anderson Raymond Director Exercise or conversion · Restricted Stock Units −751 2,254
2021-02-11 Tactic Pharma LLC 10% owner Sale −42,467 $13.30 $565K 249,200
2021-02-11 Tactic Pharma LLC 10% owner Sale −24,224 $14.09 $341K 224,976
2021-02-11 Tactic Pharma LLC 10% owner Sale −29,996 $15.12 $454K 194,980
2021-02-11 Tactic Pharma LLC 10% owner Sale −16,384 $16.44 $269K 178,596
2021-02-11 Tactic Pharma LLC 10% owner Sale −11,929 $16.90 $202K 166,667

Page 23 of 28 · 549 trades